Gilead Sciences (GILD)

R&D Expenses

$6.07B

TTM · Period ending: · USD

GILD logo

GILD R&D Expenses

Latest reported$6.07B
GILD TTM R&D Expenses ($0.00 → $6.07B)
High-resolution chart · PNG

GILD r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
6,066,000,000
5,793,000,000
5,800,000,000
5,857,000,000
5,906,000,000
5,766,000,000
5,907,000,000
5,674,000,000
5,736,000,000
5,792,000,000
5,719,000,000
3,159,000,000
2,851,000,000
2,546,000,000
4,977,000,000
8,156,000,000
8,108,000,000
8,098,000,000
5,275,000,000
4,826,000,000
4,883,000,000
5,090,000,000
5,039,000,000
5,360,000,000
5,232,000,000
4,928,000,000
4,981,000,000
5,032,000,000
4,941,000,000
5,138,000,000
5,018,000,000
4,218,000,000
4,068,000,000
3,740,000,000
3,734,000,000
3,792,000,000
4,144,000,000
4,764,000,000
5,098,000,000
4,647,000,000
4,249,000,000
3,583,000,000
3,014,000,000
3,301,632,000
3,188,632,000
2,954,632,000
2,853,632,000
2,360,978,000
2,277,222,000
2,217,124,000
2,119,756,000
2,007,437,000
1,927,024,000
1,799,366,000
1,759,945,000
1,722,522,000
1,546,757,000
1,432,916,000
1,229,151,000
1,219,675,000
1,160,049,000
1,108,712,000
1,072,930,000
919,815,000
959,231,000
969,803,000
939,918,000
902,136,000
820,342,000
755,246,000
721,768,000
704,553,000
656,848,000
616,237,000
591,026,000
517,998,000
470,946,000
425,551,000
383,861,000
341,004,000
326,529,000
295,690,000
277,724,000
279,121,000
249,495,000
235,441,000
223,552,000
206,659,000
193,435,000
191,110,000
173,705,000
155,453,000
154,811,000
142,344,000
134,758,000
144,344,000
154,734,000
167,961,000
185,553,000
184,080,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.